They wouldn't, but they don't.  Consolidated gross margins are 90% or more, if costs are measured based on raw materials and manufacturing alone, however, through transfer pricing, all the profit goes off-shore into tax havens.  Biggest pharma expense is not R&D either, it is marketing.